Company Filing History:
Years Active: 1999-2001
Title: Innovations in Insulin: The Contributions of Elsebeth Norup
Introduction
Elsebeth Norup is a notable inventor based in Jyllinge, Denmark. She has made significant contributions to the field of diabetes treatment through her innovative work on insulin compositions. With a total of 2 patents, her research focuses on improving the stability and efficacy of insulin preparations.
Latest Patents
Norup's latest patents include groundbreaking formulations aimed at enhancing insulin stability. The first patent, titled "Stabilized insulin compositions," describes an aqueous insulin composition that incorporates human insulin or its analogues, along with a buffer such as glycylglycine, citrate, or TRIS, and metal ions like calcium or magnesium. The second patent, "Insulin preparations containing NaCl," presents insulin formulations that boast superior chemical stability, comprising human insulin or its analogues, glycerol and/or mannitol, and halogenides in concentrations ranging from 5 to 100 mM.
Career Highlights
Elsebeth Norup is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has been pivotal in advancing insulin therapies, contributing to better management of diabetes for patients worldwide.
Collaborations
Norup has collaborated with esteemed colleagues, including Liselotte Langkjae Buttedr and Svend Havelund. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of diabetes treatment.
Conclusion
Elsebeth Norup's contributions to insulin formulations represent a significant advancement in diabetes care. Her innovative patents and work at Novo Nordisk A/S highlight her commitment to improving the lives of those affected by diabetes.